X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with MYLAN INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs MYLAN (US) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   MYLAN
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-17
MYLAN
Dec-14
CADILA HEALTHCARE/
MYLAN
5-Yr Chart
Click to enlarge
High Rs4603,802-   
Low Rs3052,679-   
Sales per share (Unadj.) Rs92.11,301.5-  
Earnings per share (Unadj.) Rs14.8156.8-  
Cash flow per share (Unadj.) Rs18.5252.4-  
Dividends per share (Unadj.) Rs3.200-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs68.0647.0-  
Shares outstanding (eoy) m1,023.74378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x4.22.5 166.8%   
Avg P/E ratio x25.820.7 124.9%  
P/CF ratio (eoy) x20.712.8 161.2%  
Price / Book Value ratio x5.65.0 112.3%  
Dividend payout %21.60-   
Avg Mkt Cap Rs m391,5811,226,120 31.9%   
No. of employees `00016.925.0 67.4%   
Total wages/salary Rs m15,0020-   
Avg. sales/employee Rs Th5,594.519,698.4 28.4%   
Avg. wages/employee Rs Th890.10-   
Avg. net profit/employee Rs Th899.92,373.0 37.9%   
INCOME DATA
Net Sales Rs m94,295492,459 19.1%  
Other income Rs m1,286-2,871 -44.8%   
Total revenues Rs m95,581489,588 19.5%   
Gross profit Rs m19,036122,477 15.5%  
Depreciation Rs m3,75036,169 10.4%   
Interest Rs m45021,242 2.1%   
Profit before tax Rs m16,12262,195 25.9%   
Minority Interest Rs m338-255 -132.5%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-30-   
Tax Rs m1,2892,615 49.3%   
Profit after tax Rs m15,16859,325 25.6%  
Gross profit margin %20.224.9 81.2%  
Effective tax rate %8.04.2 190.1%   
Net profit margin %16.112.0 133.5%  
BALANCE SHEET DATA
Current assets Rs m60,223432,936 13.9%   
Current liabilities Rs m53,058338,470 15.7%   
Net working cap to sales %7.619.2 39.6%  
Current ratio x1.11.3 88.7%  
Inventory Days Days7078 89.4%  
Debtors Days Days88107 82.2%  
Net fixed assets Rs m72,984113,929 64.1%   
Share capital Rs m1,02417,415 5.9%   
"Free" reserves Rs m68,5760-   
Net worth Rs m69,600244,801 28.4%   
Long term debt Rs m24,684365,708 6.7%   
Total assets Rs m152,207986,034 15.4%  
Interest coverage x36.83.9 937.6%   
Debt to equity ratio x0.41.5 23.7%  
Sales to assets ratio x0.60.5 124.0%   
Return on assets %10.38.2 125.6%  
Return on equity %21.824.2 89.9%  
Return on capital %17.913.6 131.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,4060-   
CASH FLOW
From Operations Rs m13,49564,734 20.8%  
From Investments Rs m-29,103-51,051 57.0%  
From Financial Activity Rs m23,158-17,057 -135.8%  
Net Cashflow Rs m7,556-3,374 -223.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 63.79 Rs / USD

Compare CADILA HEALTHCARE With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: J.B.CHEMICALS  TTK HEALTHCARE  STRIDES SHASUN LTD  WYETH LTD  BIOCON LTD  



Today's Market

Indian Share Markets Open Flat; Metal Stocks Witness Selling(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 0.23% while the Hang Seng is down 0.49%. The Nikkei 225 is trading down by 0.55%.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 24, 2018 11:23 AM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS